Keyphrases
Gonadotropin-releasing Hormone
100%
Controlled Ovarian Stimulation
90%
In Vitro Fertilization
85%
Ovarian Stimulation
82%
IVF Outcome
59%
IVF Cycles
53%
Multiple Dose
51%
Gonadotropins
44%
Hormone Replacement Therapy
43%
Pregnancy Rate
38%
Polycystic Ovary Syndrome
35%
GnRH Antagonist Protocol
34%
Poor Responders
34%
Follicle
32%
High-quality Embryo
31%
Luteinizing Hormone
28%
GnRH Analogue
27%
Menopause
25%
Oocyte Yield
25%
Intracytoplasmic Sperm Injection
24%
Human Menopausal Gonadotropin
24%
Follicle-stimulating Hormone
24%
Live Birth
22%
Ultrashort
20%
Improved Outcomes
20%
Israel
19%
Body Mass Index
18%
Future Fertility
18%
Attitude towards Menopause
17%
Oocyte number
17%
Femarelle
16%
Elective Egg Freezing
16%
Methotrexate
16%
Unusual Presentation
16%
Amniotic Band Syndrome
16%
DT56a
16%
Ovulation Trigger
16%
Vaginal Progesterone
16%
Letrozole
16%
Personal Care Products
16%
Phthalates
16%
Cycle Outcomes
16%
Ovarian Response
15%
Clinical Pregnancy Rate
15%
Mature Oocyte
15%
Pregnant Women
12%
Spina Bifida
12%
Abdominal Wall Defect
12%
Lordosis
12%
Scoliosis
12%
Medicine and Dentistry
Oocyte
98%
Gonadotropin-Releasing Hormone
77%
Controlled Ovarian Hyperstimulation
76%
In Vitro Fertilisation
73%
Pregnancy Rate
45%
Follitropin
44%
Hormone Substitution
43%
Embryo Quality
42%
Follicle
33%
Polycystic Ovary Syndrome
32%
Gonadorelin Agonist
32%
Multiple Drug Dose
25%
Gonadotropin
25%
Human Menopausal Gonadotropin
24%
Intracytoplasmic Sperm Injection
24%
Progesterone
19%
Luteinizing Hormone
18%
Chorionic Gonadotropin
17%
Amnion Band Syndrome
16%
Letrozole
16%
Limb
16%
Body Mass Index
15%
Health Care
14%
Embryo Transfer
14%
Fertilization
13%
Diethylstilbestrol
11%
Gonadorelin Antagonist
11%
Placenta
11%
Prevalence
11%
Pronucleus
10%
Messenger RNA
10%
Conception
10%
Population Research
10%
Health Behavior
10%
Pregnancy Complication
9%
Ovarian Reserve
9%
Ovulation
9%
In Vitro
9%
Birth Rate
8%
Gonadorelin
8%
Abdominal Wall Defect
8%
Misoprostol
8%
Pregnancy Disorder
8%
Bone Density
8%
Placenta Development
8%
Ovarian Follicle
8%
First Trimester Pregnancy
8%
Methotrexate
8%
Fetus Growth
8%
Atresia
8%
